The company also said that its full-year 2014 revenues dropped 32 percent year over year. 

The firm is now consulting with experts to evaluate detection of enteroviruses and rhinoviruses in respiratory specimens for its next-generation ePlex system.

The partners signed a CRADA to develop biomarkers discovered by the Center for Prostate Disease Research for use in clinical diagnostic testing. 

Under the agreement, iPathwayGuide will be a "featured informatics solution" for Riken-Genesis' customers, Advaita said.

Revenue from the firm's ResponseDX test jumped 16 percent in the fourth quarter of 2014 and 22 percent for the full year.

The NYGC is currently preparing to submit a number of additional clinical tests to the state including assays for cancer and constitutional disorders.

The partners will work to establish Centrum Badan as the preferred testing partner for the NGS-based test in Poland, which had 376,000 live births last year.

George Church tells The Sunday Times that his group has inserted some woolly mammoth genes into elephant cells.

The partners will integrate Strand's informatics software with MRI Global's mobile diagnostic labs and co-develop companion diagnostics.

The deal expands one reached in 2013 to discover and develop therapeutic agents targeting cancer genome alterations. 

In PNAS this week: rare variants linked to bleeding disorder, comparison of whole-exome and whole-genome sequencing, and more.

The National Cancer Institute's Harold Varmus discusses the state of cancer research with the New York Times.

After going through the consumer genomics testing process, participants maintained similar, high levels of genetic literacy, but reported lower confidence in their understanding of genetic information.

JGI is working to develop technologies around the front and back ends of NGS, and sees rising interest in synthetic biology. 

Funding for the new model for facilitating basic and translational genomic science in the country will be matched by public and private donors to create 10 research "nodes."

The company aims to seek US and European approval later this year.

Metagenomic tools are shedding light on how microbes survive in and contribute to environments ranging from wetlands to natural oil seepage sites, according to presentations at this year's ABRF meeting.

The joint venture – of which Quintiles will own 60 percent and Quest will own 40 percent – is poised to be the second largest central laboratory services firm in the world.

A Scientific Reports editor resigns over a new policy at the journal allowing researchers to pay to fast track the peer review of their manuscripts, and poll.

UC Davis' Simeon Boyd and his colleagues will continue genetic research into the condition to identify biomarkers, which could be used for early detection and treatment.

The NextSeq CN500 sequencer was developed in collaboration with Illumina to offer clinical non-invasive prenatal testing for the Chinese market.

Hairpin will be the exclusive agent for negotiating and executing new license agreements for patents covering the CSHL RNAi technology.

The deal provides PerkinElmer access to Applied BioCode's Barcoded Magnetic Bead technology, including the BioCode MDx 3000 instrument.

The study provides a public list of ADRs ranked by severity and highlights the efficacy of crowd-sourcing for pharmacovigilance studies.

Insight Genetics has named Rob Seitz as chief technology officer. As CTO, Seitz will oversee the development and commercialization of Insight's genetic assays for the identification of triple-negative breast cancer using technology licensed out of the Vanderbilt Ingram Cancer Center. Prior to joining Insight, Seitz was senior vice president for technology assessment at Clarient (part of GE Healthcare). He also was co-founder and CEO of Applied Genomics prior to its acquisition by Clarient.